Inhibition of YIPF2 Improves the Vulnerability of Oligodendrocytes to Human Islet Amyloid Polypeptide

Medicine, Neurology, Life Sciences, Cell Biology, Biochemistry,
diabetic encephalopathy   human islet amyloid polypeptide   oligodendrocytes   yeast Rab GTPase-interacting protein 2   monocarboxylate transporters   CD147  

Study on YIPF2 Inhibitors Improving Oligodendrocyte Susceptibility to Human Islet Amyloid Polypeptide With the dramatic increase in global diabetes prevalence, the harm of diabetes complications is becoming increasingly prominent. Among them, Diabetic Encephalopathy (DE), as the most common complication in type 2 diabetes, severely affects patients...